Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long ...

Elevated fat levels in your liver can raise your chances of developing serious health issues, including diabetes, ...

Alpharetta, Georgia Wednesday, February 12, 2025, 16:30 Hrs [IST] ...

BEDFORD, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular”), a biopharmaceutical ...

Multiple subcutaneous doses safe and well-tolerated >69% reduction in anti-VEGF intravitreal (IVT) treatment burden in study eyes >67% ...

REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target ...

The 36-week trial was a randomized, double-masked, parallel-group, active-controlled, multicenter evaluating CLS-AX (axitinib ...

Ocular Therapeutix, Inc. has announced its participation in the Angiogenesis, Exudation, and Degeneration 2025 virtual meeting, scheduled for February 8, 2025, where it will present new findings ...

were presented at the Angiogenesis, Exudation, and Degeneration 2025 virtual meeting on February 8, 2025. The data were presented by Michael Singer, M.D., Clinical Professor of Ophthalmology at ...

Clearside Biomedical (CLSD) announces that two subgroup analyses were presented from the ODYSSEY Phase 2b clinical trial at the Angiogenesis, ...

Fennel seeds contain anethole, a compound that has been found to exhibit anti-cancer properties by inhibiting cancer cell ...

I was recently invited to try SomaCell, a groundbreaking new FDA-cleared treatment that promises to take years off your face ...